361 related articles for article (PubMed ID: 25663530)
21. Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expression.
Tan Y; Wang L; Du Y; Liu X; Chen Z; Weng X; Guo J; Chen H; Wang M; Wang X
Int J Oncol; 2018 Dec; 53(6):2503-2517. PubMed ID: 30272279
[TBL] [Abstract][Full Text] [Related]
22. Quercetin regulates β-catenin signaling and reduces the migration of triple negative breast cancer.
Srinivasan A; Thangavel C; Liu Y; Shoyele S; Den RB; Selvakumar P; Lakshmikuttyamma A
Mol Carcinog; 2016 May; 55(5):743-56. PubMed ID: 25968914
[TBL] [Abstract][Full Text] [Related]
23. β-Catenin is required for the tumorigenic behavior of triple-negative breast cancer cells.
Xu J; Prosperi JR; Choudhury N; Olopade OI; Goss KH
PLoS One; 2015; 10(2):e0117097. PubMed ID: 25658419
[TBL] [Abstract][Full Text] [Related]
24. CircRNA_069718 promotes cell proliferation and invasion in triple-negative breast cancer by activating Wnt/β-catenin pathway.
Zhang J; Xu HD; Xing XJ; Liang ZT; Xia ZH; Zhao Y
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5315-5322. PubMed ID: 31298383
[TBL] [Abstract][Full Text] [Related]
25. Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth.
Wang Q; Zhou Y; Rychahou P; Harris JW; Zaytseva YY; Liu J; Wang C; Weiss HL; Liu C; Lee EY; Evers BM
Cancer Res; 2018 Jun; 78(12):3163-3175. PubMed ID: 29666061
[TBL] [Abstract][Full Text] [Related]
26. Expression of C-myc and β-catenin and their correlation in triple negative breast cancer.
Wang J; Li M; Chen D; Nie J; Xi Y; Yang X; Chen Y; Yang Z
Minerva Med; 2017 Dec; 108(6):513-517. PubMed ID: 28889723
[TBL] [Abstract][Full Text] [Related]
27. Loss of β-catenin in adrenocortical cancer cells causes growth inhibition and reversal of epithelial-to-mesenchymal transition.
Salomon A; Keramidas M; Maisin C; Thomas M
Oncotarget; 2015 May; 6(13):11421-33. PubMed ID: 25823656
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
[TBL] [Abstract][Full Text] [Related]
29. Expression and significance of Wnt signaling components and their target genes in breast carcinoma.
He Y; Liu Z; Qiao C; Xu M; Yu J; Li G
Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141
[TBL] [Abstract][Full Text] [Related]
30. Docosahexaenoic acid inhibited the Wnt/β-catenin pathway and suppressed breast cancer cells in vitro and in vivo.
Xue M; Wang Q; Zhao J; Dong L; Ge Y; Hou L; Liu Y; Zheng Z
J Nutr Biochem; 2014 Feb; 25(2):104-10. PubMed ID: 24290517
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas.
Bouillez A; Rajabi H; Pitroda S; Jin C; Alam M; Kharbanda A; Tagde A; Wong KK; Kufe D
Cancer Res; 2016 Mar; 76(6):1538-48. PubMed ID: 26833129
[TBL] [Abstract][Full Text] [Related]
32. Wnt signaling in triple negative breast cancer is associated with metastasis.
Dey N; Barwick BG; Moreno CS; Ordanic-Kodani M; Chen Z; Oprea-Ilies G; Tang W; Catzavelos C; Kerstann KF; Sledge GW; Abramovitz M; Bouzyk M; De P; Leyland-Jones BR
BMC Cancer; 2013 Nov; 13():537. PubMed ID: 24209998
[TBL] [Abstract][Full Text] [Related]
33. Methylprednisolone suppresses the Wnt signaling pathway in chronic lymphocytic leukemia cell line MEC-1 regulated by LEF-1 expression.
Yao QM; Li PP; Liang SM; Lu K; Zhu XJ; Liu YX; Zhang F; Yuan T; Wang X
Int J Clin Exp Pathol; 2015; 8(7):7921-8. PubMed ID: 26339357
[TBL] [Abstract][Full Text] [Related]
34. 5-Azacytidine suppresses the proliferation of pancreatic cancer cells by inhibiting the Wnt/β-catenin signaling pathway.
Zhang H; Zhou WC; Li X; Meng WB; Zhang L; Zhu XL; Zhu KX; Bai ZT; Yan J; Liu T; Xu XC; Li YM
Genet Mol Res; 2014 Jul; 13(3):5064-72. PubMed ID: 25061731
[TBL] [Abstract][Full Text] [Related]
35. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
[TBL] [Abstract][Full Text] [Related]
36. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
Chen H; Wang Y; Xue F
Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
[TBL] [Abstract][Full Text] [Related]
37. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival.
Alves-Guerra MC; Ronchini C; Capobianco AJ
Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709
[TBL] [Abstract][Full Text] [Related]
38. Differential activation of Wnt-β-catenin pathway in triple negative breast cancer increases MMP7 in a PTEN dependent manner.
Dey N; Young B; Abramovitz M; Bouzyk M; Barwick B; De P; Leyland-Jones B
PLoS One; 2013; 8(10):e77425. PubMed ID: 24143235
[TBL] [Abstract][Full Text] [Related]
39. HOXB5 induces invasion and migration through direct transcriptional up-regulation of β-catenin in human gastric carcinoma.
Hong CS; Jeong O; Piao Z; Guo C; Jung MR; Choi C; Park YK
Biochem J; 2015 Dec; 472(3):393-403. PubMed ID: 26467157
[TBL] [Abstract][Full Text] [Related]
40. Molecular determinants of Akt-induced keratinocyte transformation.
Segrelles C; Moral M; Lara MF; Ruiz S; Santos M; Leis H; García-Escudero R; Martínez-Cruz AB; Martínez-Palacio J; Hernández P; Ballestín C; Paramio JM
Oncogene; 2006 Feb; 25(8):1174-85. PubMed ID: 16247457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]